Name: Latest research reports of GlaxoSmithKline Pharmaceuticals Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: GlaxoSmithKline Pharmaceuticals Ltd.
Rating: 3
Author: ICICI Securities Limited

On road to recovery

Hold: GlaxoSmithKline Pharmaceut...

Target

ICICI Securities Limited

GlaxoSmithKline Pharmaceuticals’ (GSK) Q1FY25 result was ahead of our expectations driven by mixed improvement and curb in overhead cost.